HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Immuno-Oncologists investigate how the immune system can be leveraged to identify and destroy cancer cells. Their work centers on developing and applying treatments that stimulate or restore immune function to recognize tumors as threats. These experts utilize cutting-edge therapies such as immune checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, and cancer vaccines. By evaluating tumor genetics and immune biomarkers, they tailor treatment strategies to match the unique characteristics of each patient's cancer.
In practice, immuno-oncologists are part of a collaborative team, working alongside medical oncologists, pathologists, researchers, and other specialists to provide individualized care. They also monitor treatment responses and manage immune-related side effects, which require specialized knowledge distinct from conventional chemotherapy or radiation. Their patient-centered approach aims to improve effectiveness while minimizing harm. This field has revolutionized outcomes for patients with cancers that previously had limited treatment options. Through continuous research and clinical trials, immuno-oncologists are helping to expand the role of immunotherapy in cancer care, offering renewed hope and longer-term control for many who once faced few alternatives. They are especially critical in treating aggressive or relapsed cancers where traditional therapies have failed. Many immuno-oncologists also contribute to developing novel drug combinations and precision medicine strategies. Their work is shaping the future of oncology by aligning treatment with each patient's immune profile.
